6 substituted 2-heterocyclylamino pyrazine compounds as CHK-1 inhibitors
US8518952B2 · kind B2 · utility
11Cited by
7References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 4, 2009 |
| Grant date | Aug 27, 2013 |
| Priority date | — |
| Expiry date | Mar 13, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention is directed to compounds of formula (I),and pharmaceutically acceptable salts thereof, their synthesis, and their use as CHK-1 inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.